Epidemiology and outcomes of hyponatremia in patients with COVID-19—A territory-wide study in Hong Kong

ABSTRACT:

Background

Hyponatremia is common in COVID-19, but its epidemiology and impact on clinical outcomes in relation to different variants, especially the Omicron variant, requires further clarification.

Methods

This was a territory-wide retrospective study to investigate the epidemiology and outcomes of COVID-19 patients with hyponatremia from January 1, 2020 to March 31, 2022 in Hong Kong. The primary outcome was 30-day mortality of patients with COVID-19 and hyponatremia at presentation. Secondary outcomes included rate of hospitalization, intensive care unit (ICU) hospitalization, overall duration of hospitalization, and duration of ICU hospitalization.

Results

A total of 53,415 COVID-19 patients were included for analysis, of which 14,545 (27.2%) had hyponatremia

SUBMITTER: Chan G 

PROVIDER: S-EPMC9874105 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature